Lasa Supergenerics Ltd. benchmarking: Perfomance to industry peers

Financial

	Lasa Supergenerics	Mangalam Drugs&Org.	Bal Pharma
Operational Metrics
Financials
5 yr Average ROE	-8.32 %	7.15 %	1.96 %
5yr average Equity Multiplier	1.44	2.25	4.59
5yr Average Asset Turnover Ratio	0.77	1.24	0.98
5yr Avg Net Profit Margin	-8.22 %	2.38 %	-0.04 %
Price to Book	0.81	0.8	1.83
P/E	0.0	0.0	19.89
5yr Avg Cash Conversion Cycle	11.27 Days	51.34 Days	41.77 Days
Inventory Days	46.83 Days	94.22 Days	99.82 Days
Days Receivable	10.61 Days	27.67 Days	115.65 Days
Days Payable	83.41 Days	84.69 Days	154.91 Days
5yr Average Interest Coverage Ratio	-18.91	2.52	1.5
5yr Avg ROCE	1.03 %	15.15 %	15.4 %
5yr Avg Operating Profit Margin	9.99 %	9.09 %	7.79 %
5 yr average Debt to Equity	0.2	0.55	2.03
5yr CAGR Net Profit	n/a	n/a	8.78 %
5yr Average Return on Assets	-5.59 %	3.55 %	0.43 %
Shareholdings
Promoter Holding	53.65 %	50.3 %	50.86 %
Share Pledged by Promoters	20.66 %	13.23 %	0.0
Change in Promoter Holding (3 Yrs)	9.87 %	-0.12 %	-1.14 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Lasa Supergenerics	Mangalam Drugs&Org.	Bal Pharma
Segment Break-Up	Segment Break-Up Human & Animal API 100.0	-	-
Location Wise Break-Up	Location Wise Break-Up India 95.82 International 0 Domestic 0 Rest of the World 0 Others 4.18	Location Wise Break-Up India 0 Domestic 62.61 International 37.39 Rest of the World 0	Location Wise Break-Up India 35.85 Domestic 0 International 0 Rest of the World 64.15